Research has shown treatments that help increase participation in groups like Alcoholics Anonymous & Narcotics Anonymous result in greater likelihood of abstinence and remission for those with substance use disorder.
Research has shown treatments that help increase participation in groups like Alcoholics Anonymous & Narcotics Anonymous result in greater likelihood of abstinence and remission for those with substance use disorder.
l
For patients who have another co-occurring psychiatric disorder, especially if the other psychiatric disorder is debilitating, such as psychotic disorder or chronic major depressive disorder, studies have also shown that participation in 12-step mutual-help organizations that focus on both severe mental illness & addiction are associated with better outcomes.
The research team randomized 121 individuals with alcohol use disorder (AUD) and co-occurring psychotic (18%), bipolar (36%), or major depressive disorder (46%) attending an outpatient program that caters specifically to individuals with co-occurring disorder to receive treatment as usual (TAU; n = 38) by itself, or with an add-on Twelve-Step Facilitation (TSF) intervention designed specifically for patients with severe co-occurring disorders (n = 83).
The Twelve-Step Facilitation (TSF) treatment, adapted from the TSF intervention used in another large treatment study called Project MATCH, was tailored for those with co-occurring disorders by emphasizing:
The patients not randomized to receive the adapted Twelve-Step Facilitation (TSF) received only treatment as usual (TAU), which consisted of medication monitoring, individual therapy, and case management. In other words, all patients received treatment as usual (TAU), but TSF patients also received the intervention to encourage Double Trouble in Recovery (DTR) attendance. Even though groups were randomized in such a way as to attempt to equate them on a number of characteristics so that the only thing that differed between the groups was whether they got TSF or not, the group of patients assigned to the TSF intervention, on average, still had greater alcohol abstinence and a higher percentage of individuals with another drug use disorder (e.g., marijuana) in addition to alcohol use disorder (AUD) at the start of treatment, which the authors mention in their study limitations.
The main clinical outcomes (measured at the end of treatment (12 weeks), and 3-, 6-, and 9-month follow-up assessments) examined were:
Researchers tested whether Twelve-Step Facilitation (TSF) participants had significantly greater increases in percent days abstinent from alcohol (PDA) and significantly greater decreases in drinking intensity (DDD) during treatment and at the 9-month follow-up compared to patients receiving only TAU.
Researchers used the 12-step Participation Questionnaire to measure participants’ completion of 12-step work in addition to other central 12-step activities and beliefs including having a sponsor and considering oneself a 12-step member. Finally, it is worth highlighting the staff therapists were very well trained in the delivery of Twelve-Step Facilitation (TSF) before the study, including an intensive training period with feedback provided on videotaped sessions by the developer of Project MATCH’s TSF. Feedback was also provided to therapists during the study, and trained coders found that therapists, on average, demonstrating about 90% of the identified “ingredients” of TSF each session, suggesting they delivered the treatment as designed.
Compared to treatment as usual (TAU) patients, Twelve-Step Facilitation (TSF) patients:
Despite their greater participation in 12-step groups, Twelve-Step Facilitation (TSF) patients and treatment as usual (TAU) patients had similar positive changes in percent days abstinent from alcohol (PDA) and DDD during treatment, that were maintained, on average, by the 9-month follow-up with no group differences. They also had similar percentage of days taking their prescribed psychiatric medication and attendance at psychiatric treatment sessions. Because Twelve-Step Facilitation (TSF) promoted more 12-step attendance, but participants only attended 5 of 12 sessions on average, the researchers examined whether greater participation in TSF was associated with better outcomes.
More Twelve-Step Facilitation (TSF) treatment sessions attended were associated with better percent days abstinent from alcohol (PDA) & drinking intensity (DDD) during treatment and at the 9-month follow-up.
Several important contributions of this study:
As noted above, each additional Narcotics Anonymous (NA) meeting attended per week was associated significantly with a 2% increase in the odds of treatment retention and a 1% increase in the odds of abstinence at 6 months. Negative attitudes toward buprenorphine may begin to shift as medication-assisted treatment becomes more widely accepted as an evidence-based treatment for people seeking recovery.
This Twelve-Step Facilitation (TSF) intervention tailored specifically for patients with co-occurring alcohol and severe psychiatric disorder, with many innovative adaptations (e.g., in-session peer linkage), may promote increased 12-step participation. To date, it is the only known TSF intervention designed specifically for this patient group with severe mental health problems.
An interesting next step would be to test if group versus individual Twelve-Step Facilitation (TSF) for those with co-occurring disorders, or to add a second treatment group to test whether incentivizing treatment attendance could lead to better outcomes:
Twelve-Step Facilitation (TSF) + Contingency Management VS. Twelve-Step Facilitation (TSF) VS. treatment as usual (TAU)).
Bogenschutz, M. P., Rice, S. L., Tonigan, J. S., Vogel, H. S., Nowinski, J., Hume, D., & Arenella, P. B. (2014). 12-step facilitation for the dually diagnosed: a randomized clinical trial. J Subst Abuse Treat, 46(4), 403-411. doi: 10.1016/j.jsat.2013.12.009
l
For patients who have another co-occurring psychiatric disorder, especially if the other psychiatric disorder is debilitating, such as psychotic disorder or chronic major depressive disorder, studies have also shown that participation in 12-step mutual-help organizations that focus on both severe mental illness & addiction are associated with better outcomes.
The research team randomized 121 individuals with alcohol use disorder (AUD) and co-occurring psychotic (18%), bipolar (36%), or major depressive disorder (46%) attending an outpatient program that caters specifically to individuals with co-occurring disorder to receive treatment as usual (TAU; n = 38) by itself, or with an add-on Twelve-Step Facilitation (TSF) intervention designed specifically for patients with severe co-occurring disorders (n = 83).
The Twelve-Step Facilitation (TSF) treatment, adapted from the TSF intervention used in another large treatment study called Project MATCH, was tailored for those with co-occurring disorders by emphasizing:
The patients not randomized to receive the adapted Twelve-Step Facilitation (TSF) received only treatment as usual (TAU), which consisted of medication monitoring, individual therapy, and case management. In other words, all patients received treatment as usual (TAU), but TSF patients also received the intervention to encourage Double Trouble in Recovery (DTR) attendance. Even though groups were randomized in such a way as to attempt to equate them on a number of characteristics so that the only thing that differed between the groups was whether they got TSF or not, the group of patients assigned to the TSF intervention, on average, still had greater alcohol abstinence and a higher percentage of individuals with another drug use disorder (e.g., marijuana) in addition to alcohol use disorder (AUD) at the start of treatment, which the authors mention in their study limitations.
The main clinical outcomes (measured at the end of treatment (12 weeks), and 3-, 6-, and 9-month follow-up assessments) examined were:
Researchers tested whether Twelve-Step Facilitation (TSF) participants had significantly greater increases in percent days abstinent from alcohol (PDA) and significantly greater decreases in drinking intensity (DDD) during treatment and at the 9-month follow-up compared to patients receiving only TAU.
Researchers used the 12-step Participation Questionnaire to measure participants’ completion of 12-step work in addition to other central 12-step activities and beliefs including having a sponsor and considering oneself a 12-step member. Finally, it is worth highlighting the staff therapists were very well trained in the delivery of Twelve-Step Facilitation (TSF) before the study, including an intensive training period with feedback provided on videotaped sessions by the developer of Project MATCH’s TSF. Feedback was also provided to therapists during the study, and trained coders found that therapists, on average, demonstrating about 90% of the identified “ingredients” of TSF each session, suggesting they delivered the treatment as designed.
Compared to treatment as usual (TAU) patients, Twelve-Step Facilitation (TSF) patients:
Despite their greater participation in 12-step groups, Twelve-Step Facilitation (TSF) patients and treatment as usual (TAU) patients had similar positive changes in percent days abstinent from alcohol (PDA) and DDD during treatment, that were maintained, on average, by the 9-month follow-up with no group differences. They also had similar percentage of days taking their prescribed psychiatric medication and attendance at psychiatric treatment sessions. Because Twelve-Step Facilitation (TSF) promoted more 12-step attendance, but participants only attended 5 of 12 sessions on average, the researchers examined whether greater participation in TSF was associated with better outcomes.
More Twelve-Step Facilitation (TSF) treatment sessions attended were associated with better percent days abstinent from alcohol (PDA) & drinking intensity (DDD) during treatment and at the 9-month follow-up.
Several important contributions of this study:
As noted above, each additional Narcotics Anonymous (NA) meeting attended per week was associated significantly with a 2% increase in the odds of treatment retention and a 1% increase in the odds of abstinence at 6 months. Negative attitudes toward buprenorphine may begin to shift as medication-assisted treatment becomes more widely accepted as an evidence-based treatment for people seeking recovery.
This Twelve-Step Facilitation (TSF) intervention tailored specifically for patients with co-occurring alcohol and severe psychiatric disorder, with many innovative adaptations (e.g., in-session peer linkage), may promote increased 12-step participation. To date, it is the only known TSF intervention designed specifically for this patient group with severe mental health problems.
An interesting next step would be to test if group versus individual Twelve-Step Facilitation (TSF) for those with co-occurring disorders, or to add a second treatment group to test whether incentivizing treatment attendance could lead to better outcomes:
Twelve-Step Facilitation (TSF) + Contingency Management VS. Twelve-Step Facilitation (TSF) VS. treatment as usual (TAU)).
Bogenschutz, M. P., Rice, S. L., Tonigan, J. S., Vogel, H. S., Nowinski, J., Hume, D., & Arenella, P. B. (2014). 12-step facilitation for the dually diagnosed: a randomized clinical trial. J Subst Abuse Treat, 46(4), 403-411. doi: 10.1016/j.jsat.2013.12.009
l
For patients who have another co-occurring psychiatric disorder, especially if the other psychiatric disorder is debilitating, such as psychotic disorder or chronic major depressive disorder, studies have also shown that participation in 12-step mutual-help organizations that focus on both severe mental illness & addiction are associated with better outcomes.
The research team randomized 121 individuals with alcohol use disorder (AUD) and co-occurring psychotic (18%), bipolar (36%), or major depressive disorder (46%) attending an outpatient program that caters specifically to individuals with co-occurring disorder to receive treatment as usual (TAU; n = 38) by itself, or with an add-on Twelve-Step Facilitation (TSF) intervention designed specifically for patients with severe co-occurring disorders (n = 83).
The Twelve-Step Facilitation (TSF) treatment, adapted from the TSF intervention used in another large treatment study called Project MATCH, was tailored for those with co-occurring disorders by emphasizing:
The patients not randomized to receive the adapted Twelve-Step Facilitation (TSF) received only treatment as usual (TAU), which consisted of medication monitoring, individual therapy, and case management. In other words, all patients received treatment as usual (TAU), but TSF patients also received the intervention to encourage Double Trouble in Recovery (DTR) attendance. Even though groups were randomized in such a way as to attempt to equate them on a number of characteristics so that the only thing that differed between the groups was whether they got TSF or not, the group of patients assigned to the TSF intervention, on average, still had greater alcohol abstinence and a higher percentage of individuals with another drug use disorder (e.g., marijuana) in addition to alcohol use disorder (AUD) at the start of treatment, which the authors mention in their study limitations.
The main clinical outcomes (measured at the end of treatment (12 weeks), and 3-, 6-, and 9-month follow-up assessments) examined were:
Researchers tested whether Twelve-Step Facilitation (TSF) participants had significantly greater increases in percent days abstinent from alcohol (PDA) and significantly greater decreases in drinking intensity (DDD) during treatment and at the 9-month follow-up compared to patients receiving only TAU.
Researchers used the 12-step Participation Questionnaire to measure participants’ completion of 12-step work in addition to other central 12-step activities and beliefs including having a sponsor and considering oneself a 12-step member. Finally, it is worth highlighting the staff therapists were very well trained in the delivery of Twelve-Step Facilitation (TSF) before the study, including an intensive training period with feedback provided on videotaped sessions by the developer of Project MATCH’s TSF. Feedback was also provided to therapists during the study, and trained coders found that therapists, on average, demonstrating about 90% of the identified “ingredients” of TSF each session, suggesting they delivered the treatment as designed.
Compared to treatment as usual (TAU) patients, Twelve-Step Facilitation (TSF) patients:
Despite their greater participation in 12-step groups, Twelve-Step Facilitation (TSF) patients and treatment as usual (TAU) patients had similar positive changes in percent days abstinent from alcohol (PDA) and DDD during treatment, that were maintained, on average, by the 9-month follow-up with no group differences. They also had similar percentage of days taking their prescribed psychiatric medication and attendance at psychiatric treatment sessions. Because Twelve-Step Facilitation (TSF) promoted more 12-step attendance, but participants only attended 5 of 12 sessions on average, the researchers examined whether greater participation in TSF was associated with better outcomes.
More Twelve-Step Facilitation (TSF) treatment sessions attended were associated with better percent days abstinent from alcohol (PDA) & drinking intensity (DDD) during treatment and at the 9-month follow-up.
Several important contributions of this study:
As noted above, each additional Narcotics Anonymous (NA) meeting attended per week was associated significantly with a 2% increase in the odds of treatment retention and a 1% increase in the odds of abstinence at 6 months. Negative attitudes toward buprenorphine may begin to shift as medication-assisted treatment becomes more widely accepted as an evidence-based treatment for people seeking recovery.
This Twelve-Step Facilitation (TSF) intervention tailored specifically for patients with co-occurring alcohol and severe psychiatric disorder, with many innovative adaptations (e.g., in-session peer linkage), may promote increased 12-step participation. To date, it is the only known TSF intervention designed specifically for this patient group with severe mental health problems.
An interesting next step would be to test if group versus individual Twelve-Step Facilitation (TSF) for those with co-occurring disorders, or to add a second treatment group to test whether incentivizing treatment attendance could lead to better outcomes:
Twelve-Step Facilitation (TSF) + Contingency Management VS. Twelve-Step Facilitation (TSF) VS. treatment as usual (TAU)).
Bogenschutz, M. P., Rice, S. L., Tonigan, J. S., Vogel, H. S., Nowinski, J., Hume, D., & Arenella, P. B. (2014). 12-step facilitation for the dually diagnosed: a randomized clinical trial. J Subst Abuse Treat, 46(4), 403-411. doi: 10.1016/j.jsat.2013.12.009